The new quest in CTLA-4 insufficiency: How to immune modulate effectively?

J Allergy Clin Immunol. 2022 Feb;149(2):543-546. doi: 10.1016/j.jaci.2021.11.020. Epub 2021 Dec 13.
No abstract available

Keywords: CTLA-4 insufficiency; abatacept; immune dysregulation; transendocytosis; treatment.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Abatacept
  • B7-2 Antigen
  • CTLA-4 Antigen*
  • Humans

Substances

  • B7-2 Antigen
  • CTLA-4 Antigen
  • Abatacept